Vivani Medical Developing Semaglutide Implant for Obesity and Diabetes
Vivani Medical’s GLP-1 Implant Strategy Targets Long-Term Weight Management Vivani Medical (NASDAQ: VVM) is developing a miniature, subcutaneous implant designed to deliver sustained, steady-state doses of semaglutide. By targeting the ... Read More